TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Cordycepin, Apatinib
Phytochemical Name Cordycepin (PubChem CID: 6303 )
Anticancer drug Name Apatinib (PubChem CID: 11315474 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 935
Pair Name Cordycepin, Apatinib
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Down-regulation Phosphorylation AKT1 hsa207
Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Up-regulation Cleavage CASP3 hsa836
Down-regulation Phosphorylation PIK3CA hsa5290
Down-regulation Expression VEGFA hsa7422
In Vitro Model A-549 Lung adenocarcinoma Homo sapiens (Human) CVCL_0023
PC-9 Lung adenocarcinoma Homo sapiens (Human) CVCL_B260
Result Our findings demonstrated that the combination of cordycepin and apatinib has synergistically anticancer effect on NSCLC cells by down-regulating VEGF/PI3K/Akt signaling pathway. This result indicated that cordycepin and apatinib could be a promising drug combination against NSCLC.
03. Reference
No. Title Href
1 Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling Pathway. Front Oncol. 2020 Sep 7;10:1732. doi: 10.3389/fonc.2020.01732. Click
It has been 47016 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP